Related Experiment Video
Updated: Apr 21, 2026
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
No independent association between lymph node metastasis location and recurrence in papillary thyroid carcinoma: a
Chun Huang1, Shiying Yang1, Zhuolin Dai1
1Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Background:
Whether lymph node metastasis in different anatomical regions of papillary thyroid carcinoma affects recurrence-free survival is controversial. This long-term follow-up study aims to evaluate the impact of lymph node metastasis region on recurrence-free survival and identify independent recurrence factors.
Materials And Methods:
This cross-sectional study included 1,378 patients who underwent at least unilateral thyroid lobectomy plus central and lateral lymph node dissection. Propensity score matching, Cox proportional hazards regression, and time-dependent receiver operating characteristic curve analysis were performed to assess recurrence-free survival, recurrence predictors, and predictive accuracy.
Results:
Among 1,378 patients, isolated central, lateral, and combined lymph node metastasis occurred in 361 (26.2%), 75 (5.4%), 584 (42.4%), respectively. With 91-month median follow-up, 43 (3.1%) developed recurrence. Prior to matching, patients with lateral lymph node metastasis demonstrated significantly poorer recurrence-free survival compared to those without lateral nodal involvement (p < 0.001). Propensity-matched comparisons revealed no significant recurrence-free survival differences between different anatomical regions. Male (HR = 2.317), clinically lymph node positive (HR = 3.811), and lymph node metastasis ratio > 26.3% (HR = 6.735) were independent recurrence factors in multivariate Cox analysis, with a concordance index of 0.789 (95% CI: 0.776 - 0.802).
Conclusions:
The anatomical region of lymph node metastasis was not an independent risk factor for recurrence free survival in papillary thyroid carcinoma patients. Male, clinically lymph node positive, and lymph node metastasis ratio > 26.3% were independent recurrence risk factors. For patients with high-risk recurrence factors, close clinical surveillance should be considered.
